Back to Search
WILLIAM EBERT, MD
MD
Family Medicine Physician
NPI: 1982609848Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
G77739(CA)
Research & Publications (20)
Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
PMID 18083270·Lung Cancer·2008
8-other
Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
PMID 18007150·Invest Radiol·2007
7-preclinical
Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
PMID 17562810·Radiology·2007
7-preclinical
Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
PMID 16969475·Oncol Rep·2006
8-other
Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
PMID 16428979·Invest Radiol·2006
4-observational
Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents.
PMID 16279808·J Med Chem·2005
4-observational
High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
PMID 15906334·J Magn Reson Imaging·2005
4-observational
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.
PMID 15749976·Radiology·2005
8-other
First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
PMID 15523717·NMR Biomed·2004
3-trial
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.
PMID 15150567·Br J Cancer·2004
1-meta
Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study.
PMID 15044749·Radiology·2004
3-trial
Accentuation of high susceptibility of hypertrophied myocardium to ischemia: complementary assessment of Gadophrin-enhancement and left ventricular function with MRI.
PMID 15004797·Magn Reson Med·2004
4-observational
Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.
PMID 12835227·Circulation·2003
4-observational
[MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
PMID 12811696·Rofo·2003
4-observational
Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3.
PMID 12755535·Acad Radiol·2003
7-preclinical
Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders.
PMID 12675521·Biol Chem·2003
4-observational
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
PMID 12636057·Clin Chem Lab Med·2003
4-observational
MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
PMID 12563140·Radiology·2003
7-preclinical
Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
PMID 12449357·Acad Radiol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2025 SOQUEL AVE
SANTA CRUZ, CA 95062 - Phone
- (831) 458-5524
Quick Facts
- NPI
- 1982609848
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile